Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Orphan drug tax credit

Executive Summary

Orphan drug tax credit: House legislation making orphan drug tax credit permanent and permitting a carry over of unused credits is expected to be considered as part of the Ways & Means Committee's budget reconciliation package. The committee is expected to begin work before House recess starts Aug. 4. An orphan drug tax measure, HR 1566, was introduced May 3 by Ways & Means Oversight Chairman Johnson (R-Conn.) and co-sponsored by Rep. Matsui (D-Calif.). Companion legislation, S 1052, was introduced by Sen. Hatch (R-Utah) and co-sponsored by Sen. Baucus (D-Mon.) July 20...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS026564

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel